C Borralleras, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, J M Eiros, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, M Fernández-Prada, A Gil de Miguel, G Mirada Masip, F Moraga-Llop, D Ocaña Rodríguez, J Puig-Barberà, J Vázquez, J Vergara-Alert, S de Cambra
{"title":"Bimervax®免疫原性振幅的最新进展。扩展研究(NTC05142553)对XBB.1.5的体液应答的见解。","authors":"C Borralleras, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, J M Eiros, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, M Fernández-Prada, A Gil de Miguel, G Mirada Masip, F Moraga-Llop, D Ocaña Rodríguez, J Puig-Barberà, J Vázquez, J Vergara-Alert, S de Cambra","doi":"10.37201/req/085.2023","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10710682/pdf/","citationCount":"0","resultStr":"{\"title\":\"Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553).\",\"authors\":\"C Borralleras, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, J M Eiros, J Castrodeza Sanz, P Arrazola, C Cámara Hijón, M Fernández-Prada, A Gil de Miguel, G Mirada Masip, F Moraga-Llop, D Ocaña Rodríguez, J Puig-Barberà, J Vázquez, J Vergara-Alert, S de Cambra\",\"doi\":\"10.37201/req/085.2023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21232,\"journal\":{\"name\":\"Revista Espanola De Quimioterapia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10710682/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola De Quimioterapia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.37201/req/085.2023\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Quimioterapia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37201/req/085.2023","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/8 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
期刊介绍:
The official journal of the Sociedad Española de Quimioterapia (Spanish Society of Chemotherapy), publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents primarily in human medicine. Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Publisher. All manuscripts are free open access. Revista Española de Quimioterapia includes the following sections: reviews, original articles, brierf reports, letters, and consensus documents.